Two recent studies on EMT may revise the field’s understanding of the process – but it’s important to keep in mind the limitations.

Sitting Down With… Robert A. Weinberg, founding member of the Whitehead Institute for Biomedical Research and Professor of Biology at the Massachusetts Institute of Technology, USA.

As cancer rates continue to climb, low and middle income countries are ramping up prevention and screening efforts.

What does it take to create a competitive companion diagnostic? Bharathi Vennapusa outlines her role in the development and approval of the ALK CDx – a fully-automated immunohistochemistry assay that identifies lung cancer patients who may be eligible for treatment with Pfizer’s Xalkori (crizotinib).

New software couples computer programming with cell function using the ultimate coding language: DNA

When it comes to prognosis, the mouse models I use to study amyotrophic lateral sclerosis (ALS) are sadly accurate – like their human counterparts with familial ALS, all mice with these mutations die young. After 20 years of trying – and failing – to find a treatment that could extend life, I was close to giving up, until a new drug candidate came along. Then something amazing happened – a mouse lived.

Long thought to be a key component of the metastatic process, researchers are now questioning long-held beliefs on the role of the epithelial-to-mesenchymal transition.

Scientists from opposite ends of the translational spectrum have teamed up to help solve a pressing problem in Alzheimer’s research. By creating a human equivalent to the water mazes used in rodent studies, they hope to allow easier comparison of data from animal and human studies.

Mobile devices promise a new future of point-of-care diagnostics for all

When it comes to industry–academia partnerships, it’s quality – not quantity – that counts.